Skip to main content
Friday
February 03, 2023
Sign In
Subscribe
Home
Economy
Aviation
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
World+Biz
Sports
Features
Book Review
Brands
Earth
Explorer
Fact Check
Family
Food
Game Reviews
Good Practices
Habitat
Humour
In Focus
Luxury
Mode
Panorama
Pursuit
Wealth
Wellbeing
Wheels
Epaper
More
Subscribe
Videos
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
COVID-19
Games
Long Read
Interviews
Offbeat
Podcast
Quiz
Tech
Trial By Trivia
Magazine
বাংলা
FRIDAY,
FEBRUARY 03, 2023
BionTech
World+Biz
BioNTech starts human trial to test malaria vaccine
Coronavirus chronicle
Pfizer, BioNTech start Covid-flu combination vaccine study
Health
Cancer vaccine may be ready by 2030, say founders of Covid-19 vaccine maker BioNTech
Coronavirus chronicle
BioNTech, Pfizer to start testing universal vaccine for coronaviruses
Coronavirus chronicle
Pfizer and BioNTech Omicron-targeted vaccine delayed - BioNTech CEO
Videos
Pfizer, BioNTech start testing Omicron vaccine
Coronavirus chronicle
Pfizer and BioNTech launch trial of Omicron-targeted Covid vaccine
Coronavirus chronicle
Pfizer, BioNTech vaccine neutralises Omicron with three shots
Coronavirus chronicle
Pfizer, BioNTech, Moderna making $1,000 profit every second: Analysis
Coronavirus chronicle
BioNTech sees up to 17 bln eur in vaccine revenue this year
Coronavirus chronicle
US FDA advisers back Pfizer/BioNTech Covid-19 vaccine for children
World+Biz
Civil society calls on candidates for German chancellor to waive intellectual property rules on Covid vaccines
Global Economy
BioNTech alone could lift German economy by 0.5% this year - economist
Show More